Showing results (1-10 of 46) with videos related to
Sort By:
Pageof 5
Managed Care Interface|December 29, 2007
The Medicare Part D doughnut hole: effect on pharmacy utilizationShawn X Sun, Kwan Y LeeClinical Therapeutics|March 14, 2009
Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarctionShawn X Sun, Xiaolan Ye, Kwan Y Lee, et al.Current Medical Research and Opinion|July 4, 2007
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilizationShawn X Sun, Kwan Y Lee, Carl T Bertram, et al.Expert Review of Hematology|January 19, 2023
Microsimulation to compare activity-related bleed risks between pharmacokinetic-guided rurioctocog alfa pegol prophylaxis and emicizumabShawn X Sun, Samuel CrawfordHealth Affairs (Project Hope)|November 6, 2007
The impact of Medicare Part D on prescription drug use by the elderlyFrank R Lichtenberg, Shawn X SunAmerican Health & Drug Benefits|September 9, 2016
Benefits of Early Roflumilast Treatment After Hospital or Emergency Department Discharge for a COPD ExacerbationQing Lee, Michelle Mocarski, Shawn X SunJournal of Blood Medicine|October 3, 2022
Comparison of Real-World Dose and Consumption for Two Extended Half-Life Recombinant Factor VIII Products for the Treatment of Hemophilia A in the United StatesYanyu Wu, Shawn X Sun, Tao FanThe Joint Commission Journal on Quality Improvement|March 21, 2002
Using comparison charts to assess performance measurement dataKwan Y Lee, Christine McGreeveyClinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 1, 2022
Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional StudyPing Du, George Morgan, Sarah Brighton, et al.Managed Care (Langhorne, Pa.)|September 25, 2015
Roflumilast: Who Is Using It and How It Affects Health Care Resource Utilization and CostsRahul Jain, Qian Cai, Shawn X Sun, et al.Pageof 5